The A1 adenosine receptor antagonist 1,3, dipropyl-8-cyclopentylxanthine (DPCPX) displays adenosine agonist properties in the FRTL5 thyroid cell line

This publication has 15 references indexed in Scilit:

• Adenosine Inhibition of the Hormonal Response in the Sertoli Cell Is Reversed by Pertussis Toxin*
  Endocrinology, 1988
• Adenosine 3′,5′-Monophosphate Mediates Both the Mitogenic Effect of Thyrotropin and Its Ability to Amplify the Response to Insulin-Like Growth Factor I in FRTL5 Cells*
  Endocrinology, 1988
• Adenosine Modulates Insulin Activation of Insulin Receptor Kinase in Intact Rat Adipocytes*
  Endocrinology, 1987
• PD 116,948, a highly selective A1 adenosine receptor antagonist
  Life Sciences, 1987
• Characterization of Adenosine Receptors in the PC 12 Pheochromocytoma Cell Line Using Radioligand Binding: Evidence for A‐2 Selectivity
  Journal of Neurochemistry, 1987
• Properties and Regulation of the Thyrotropin Receptor in the FRTL5 Rat Thyroid Cell Line*
  Endocrinology, 1986
• 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) inhibition of [3H]N-ethylcar☐amidoadenosine (NECA) binding allows the visualization of putative non-A1 adenosine receptors
  Brain Research, 1986
• Adenosine Modulates the Generation of Superoxide Anion by Stimulated Human Neutrophils via Interaction with a Specific Cell Surface Receptora
  Annals of the New York Academy of Sciences, 1985
• Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
• Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex
  Canadian Journal of Physiology and Pharmacology, 1979